Quantitative Signal Detection for COVID-19 Medicinal Products Based on Retrospective Analysis of Spontaneous Reports from the Russian Pharmacovigilance Database

Quantitative Signal Detection for COVID-19 Medicinal Products Based on Retrospective Analysis of Spontaneous Reports from the Russian Pharmacovigilance Database

SCIENTIFIC RELEVANCE. The pandemic of novel coronavirus infection (COVID-19) led to a drastic increase in the use of medicinal products of various therapeutic groups and increased spontaneous reporting of adverse drug reactions (ADRs). Therefore, it is necessary to analyse the reported information t...

Full description

Bibliographic Details
Main Authors: S. A. Mishinova, A. S. Kolbin, Yu. S. Polushin, E. V. Verbickaya
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-04-01
Series:Безопасность и риск фармакотерапии
Subjects:
pharmacovigilance
covid-19
adverse drug reactions
safety signal
drug safety
disproportionality analysis
quantitative methods
medicinal products
Online Access:https://www.risksafety.ru/jour/article/view/382

Similar Items

Similar Items